✦ LIBER ✦

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

✍ Scribed by Chris H Polman; Antonio Bertolotto; Florian Deisenhammer; Gavin Giovannoni; Hans-Peter Hartung; Bernhard Hemmer; Joep Killestein; Henry F McFarland; Joel Oger; Andrew R Pachner; John Petkau; Anthony T Reder; Stephen C Reingold; Huub Schellekens; Per Soelberg Sørensen

Book ID: 114409512
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 206 KB
Volume: 9
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(10)70103-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical importance of neutralising anti

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

✍ Per Soelberg Sorensen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen; Je 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 129 KB

Fate of multiple sclerosis patients posi

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments

✍ S. Malucchi; M. Capobianco; F. Gilli; F. Marnetto; M. Caldano; A. Sala; A. Berto 📂 Article 📅 2005 🏛 Springer Milan 🌐 English ⚖ 35 KB

Clinical significance of antibodies to i

Clinical significance of antibodies to interferon beta therapy in patients with relapsing–remitting multiple sclerosis

✍ Klaus Bendtzen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Immune response to immunotherapy: the ro

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis

✍ Bernhard Hemmer; Olaf Stüve; Bernd Kieseier; Huub Schellekens; Hans-Peter Hartun 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 371 KB

Impact of neutralizing antibodies on the

Impact of neutralizing antibodies on the clinical efficacy of interferon beta in multiple sclerosis

✍ Timothy Vartanian; Per Sölberg Sørensen; George Rice 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 313 KB

Predictors of long–term clinical respons

Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis

✍ V. Tomassini; A. Paolillo; P. Russo; E. Giugni; L. Prosperini; C. Gasperini; G. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 261 KB